What is SmithRX?
SmithRx is a technology-driven Pharmacy Benefit Manager (PBM) focused on reducing total drug costs and enhancing health outcomes through a transparent, 100% pass-through pricing model and advanced PBM technology. The company leverages its cloud infrastructure and a network of hundreds of broker and TPA partners to deliver lower pharmacy costs for employers. SmithRx's offerings include clinical programs and alternative sourcing via SmithRx Connect, empowering members to manage prescription benefits and decrease overall drug spend. Founded with a mission for simplicity and transparency, SmithRx operates with offices in California and Utah, positioning itself as a modern alternative to traditional PBMs.
How much funding has SmithRX raised?
SmithRX has raised a total of $89.3M across 4 funding rounds:
Series A
$9M
Debt
$350K
Series B
$20M
Series C
$60M
Series A (2018): $9M with participation from NextGen Venture Partners, Box Group, and Blumberg Capital
Debt (2020): $350K led by PPP
Series B (2022): $20M supported by Venrock and Founders Fund
Series C (2024): $60M featuring Venrock
Key Investors in SmithRX
Venrock
Venrock is a historic venture capital firm founded in 1969, known for partnering with founders to build innovative, high-growth companies. They provide entrepreneurial support, strategic guidance, and deep industry expertise, particularly in technology and healthcare ventures.
NextGen Venture Partners
NextGen Venture Partners is dedicated to the professional development and networking of emerging Venture Capital investors, fostering growth and leadership within the industry through events and community building.
Founders Fund
Founders Fund invests in significant global companies across all sectors and stages, leveraging the experience of its partners who have founded and funded major tech companies like PayPal, SpaceX, and Facebook.
What's next for SmithRX?
The recent major enterprise-level funding positions SmithRX for significant expansion and further technological development. This capital infusion is expected to fuel strategic initiatives aimed at broadening its market reach and enhancing its innovative PBM platform. As SmithRX continues to scale, its focus on transparent pricing and advanced technology will likely solidify its competitive advantage in the evolving healthcare landscape, attracting more employer partnerships and driving further growth.
See full SmithRX company page
